Clover Corporations (ASX:CLV) half yearly numbers delivered impressive underlying EBITDA growth of 50.3%. The company continues to make strong progress in its core Asia Pacific market. Growth has been driven by a combination of strong omega3 demand in its traditional infant food formula applications and new product sales. We believe the company is well poised to continue this growth into the 2nd HY10. Its Future Foods joint venture is however a concern, though management of the unit is now under control, we have adjusted our medium term forecast for the 50% owned business. download of this report go to;
http://www.microequities.com.au
CLV Price at posting:
27.5¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)